Form D · Other Health Care
GlucoVista Inc.
Fairfield, NJ · CIK 0001661552
Offering snapshot reported Dec 22, 2015 · SEC filing
- Reported sold
- $2.73M Offering amount: $10M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 10, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 22, 2015 | Initial | $2,727,296 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-253592
Source: Form D, filed Dec 22, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Anders Brag | Director |
| James Burke | Director |
| Jonathan Gerlitz | Director |
| Efraim Landa | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
277 Fairfield Road Suite 336
Fairfield, NJ, 07004
Fairfield, NJ, 07004